KRYZA David

KRYZA David

Fonction : Maitre de conférence

Equipe : GEPHARM

Bureau : Rock

Téléphone : 04 78 78 29 06

e-mail : david.kryza@univ-lyon1.fr M’envoyer un message

Spécialité :

Génie Pharmaceutique</



32 documents

  • Olga Kochebina, Adrien Halty, Jacqueline Taleb, David Kryza, Marc Janier, et al.. In vivo gadolinium nanoparticle quantification with SPECT/CT. EJNMMI Physics, Springer-Verlag, 2019, 6 (1), ⟨10.1186/s40658-019-0246-y⟩. ⟨hal-02161585⟩
  • Aurélie Moreau, Anne Laure Giraudet, Thomas Mognetti, David Kryza. Retroperitoneal fibrosis in on-going anti-PD-1 immunotherapy detected with [18F]-FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2019, ⟨10.1007/s00259-019-04352-1⟩. ⟨hal-02139023⟩
  • A.L. Giraudet, Aurélie Moreau, David Kryza. The French experience of PSMA PET for the diagnosis of biological recurrence of prostate cancer. Médecine Nucléaire, Elsevier/Masson, 2019, ⟨10.1016/j.mednuc.2019.04.004⟩. ⟨hal-02139029⟩
  • Anne-Laure Giraudet, Philippe Cassier, Chicaco Iwao-Fukukawa, Gwenaelle Garin, Jean-Noël Badel, et al.. A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients. BMC Cancer, BioMed Central, 2018, 18 (1), ⟨10.1186/s12885-018-4544-x⟩. ⟨hal-01840634⟩
  • Gabriel de Crozals, David Kryza, Gloria Jiménez Sánchez, Stéphane Roux, Doriane Mathé, et al.. Granulocyte Colony-Stimulating Factor Nanocarriers for Stimulation of the Immune System (Part I): Synthesis and Biodistribution Studies. Bioconjugate Chemistry, American Chemical Society, 2018, 29 (3), pp.795 - 803. ⟨10.1021/acs.bioconjchem.7b00605⟩. ⟨hal-01767382⟩
  • David Kryza, Gabriel de Crozals, Doriane Mathé, Jacqueline Taleb Sidi-Boumedine, Marc Janier, et al.. Granulocyte-Colony Stimulating Factor Nanocarriers for Stimulation of the Immune System (Part II): Dose-Dependent Biodistribution and In Vivo Antitumor Efficacy in Combination with Rituximab. Bioconjugate Chemistry, American Chemical Society, 2018, 29 (3), pp.804 - 812. ⟨10.1021/acs.bioconjchem.7b00606⟩. ⟨hal-01767371⟩
  • David Kryza, Olga Kochebina, Adrien Halty, Jacqueline Taleb, David Kryza T, et al.. Quantification of Gd-Nanoparticles Concentration with SPECT and Spectral Photon Counting CT. Conference: 2017 IEEE Nuclear Science Symposium and Medical Imaging Conference, Oct 2017, Atlanta, United States. pp.1-5. ⟨hal-02139139⟩
  • A.L. Giraudet, David Kryza, A. Flechon. La TEP au 68Ga-PSMA et autres traceurs TEP. Médecine Nucléaire, Elsevier/Masson, 2017, 41 (3), pp.223-227. ⟨10.1016/j.mednuc.2017.02.013⟩. ⟨hal-02139034⟩
  • Aurélie Moreau, Anne Giraudet, David Kryza, Françoise Borson-Chazot, Claire Bournaud, et al.. Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT. Nuclear Medicine Communications, Lippincott, Williams & Wilkins, 2017, 38 (9), pp.771-779. ⟨10.1097/MNM.0000000000000708⟩. ⟨hal-02139119⟩
  • Aurélie Moreau, Anne Laure Giraudet, David Kryza, Françoise Borson-Chazot, Claire Bournaud-Salinas, et al.. FDOPA Patterns in Adrenal Glands. Clinical Nuclear Medicine, Lippincott, Williams & Wilkins, 2017, 42 (5), pp.379-382. ⟨10.1097/RLU.0000000000001636⟩. ⟨hal-02139123⟩